全文获取类型
收费全文 | 6616篇 |
免费 | 550篇 |
国内免费 | 205篇 |
专业分类
耳鼻咽喉 | 84篇 |
儿科学 | 151篇 |
妇产科学 | 215篇 |
基础医学 | 571篇 |
口腔科学 | 92篇 |
临床医学 | 656篇 |
内科学 | 1016篇 |
皮肤病学 | 196篇 |
神经病学 | 239篇 |
特种医学 | 346篇 |
外国民族医学 | 1篇 |
外科学 | 778篇 |
综合类 | 985篇 |
一般理论 | 2篇 |
预防医学 | 662篇 |
眼科学 | 87篇 |
药学 | 544篇 |
7篇 | |
中国医学 | 421篇 |
肿瘤学 | 318篇 |
出版年
2023年 | 48篇 |
2022年 | 90篇 |
2021年 | 156篇 |
2020年 | 125篇 |
2019年 | 73篇 |
2018年 | 111篇 |
2017年 | 98篇 |
2016年 | 93篇 |
2015年 | 177篇 |
2014年 | 220篇 |
2013年 | 291篇 |
2012年 | 388篇 |
2011年 | 417篇 |
2010年 | 317篇 |
2009年 | 292篇 |
2008年 | 320篇 |
2007年 | 350篇 |
2006年 | 298篇 |
2005年 | 233篇 |
2004年 | 200篇 |
2003年 | 186篇 |
2002年 | 179篇 |
2001年 | 135篇 |
2000年 | 113篇 |
1999年 | 100篇 |
1998年 | 63篇 |
1997年 | 55篇 |
1996年 | 46篇 |
1995年 | 62篇 |
1994年 | 42篇 |
1993年 | 47篇 |
1992年 | 98篇 |
1991年 | 107篇 |
1990年 | 95篇 |
1989年 | 107篇 |
1988年 | 95篇 |
1987年 | 72篇 |
1986年 | 90篇 |
1985年 | 93篇 |
1984年 | 73篇 |
1983年 | 52篇 |
1975年 | 41篇 |
1973年 | 43篇 |
1972年 | 47篇 |
1959年 | 51篇 |
1958年 | 105篇 |
1957年 | 107篇 |
1956年 | 79篇 |
1955年 | 82篇 |
1954年 | 69篇 |
排序方式: 共有7371条查询结果,搜索用时 15 毫秒
1.
P Tugwell L Hart G Kraag A Park C Dok F Bianchi C Goldsmith W W Buchanan 《The Journal of rheumatology》1984,11(4):457-461
A crossover double-blind controlled trial was performed on 36 patients with rheumatoid arthritis to assess the necessity for serum salicylate monitoring in determining optimal dosage. There was no clinically or statistically significant increase in the clinical improvement of patients associated with serum monitoring but potentially toxic serum levels occurred without tinnitus when serum monitoring was not used. 相似文献
2.
多级图像对比度放大技术在膝关节摄影中的应用 总被引:1,自引:0,他引:1
目的:分析评价膝关节摄影中多级图像对比度放大技术(MUSICA)参数设定的成像效果,为实际临床应用提供理论指导。方法:随机抽取膝关节侧位软拷贝图像70例,以骨皮质、骨小梁、肌间隙、髌上囊、皮下脂肪为比对目标,由三位观察者对其显示情况进行分析,并对结果进行统计分析。结果:MUSICA处于较小值(0~2)时,适合于软组织显示,但图像锐利度欠缺;处于较高值时(4~6)适合于观察骨皮质、小梁等细节信息,但较多地出现伪影,共25例;处于2~4时整体影像对比度适中,如实反映人体密度结构。结论:作图像处理时应将MUSICA为2~4设定为常规,实际应用通常情况下可以选择该处理方法,但应根据具体要求适当调整MUSICA参数值。 相似文献
3.
4.
以链脲佐菌素制备糖尿病大鼠模型,造模后以还原型谷胱甘肽(GSH)治疗12周,结果显示GSH治疗组较糖尿病组心肌组织病理学损害改善,NF—κB活性降低,诱导型一氧化氮合酶表达下降。 相似文献
5.
6.
Michael Robson Isabelle Côte Ian Abbs Geoffrey Koffman David Goldsmith 《American journal of transplantation》2003,3(3):324-327
Thrombotic microangiopathy is a rare but important finding in the context of organ transplantation. Acute renal insufficiency in the setting of hemolysis and thrombocytopenia, a triad that constitutes 'hemolytic uremic syndrome', can be associated with, or triggered by, conditions such as verocytotoxin-producing Escherichia coli, viral infections, malignant hypertension, scleroderma, allograft rejection, lupus erythematosus, pregnancy, and medications including mitomycin C, calcineurin inhibitors, and oral contraceptives. After renal transplantation, it can occur, as either a de novo episode, or recurrent disease. Calcineurin inhibitors have long been associated with post-transplantation thrombotic microangiopathy. Sirolimus has been used as a primary immunosuppressant in patients transplanted with a history of earlier hemolytic-uremic syndrome, and also as rescue therapy in patients with calcineurin-inhibitor-associated thrombotic microangiopathy. We describe four cases where there was significant thrombotic microangiopathy in the context of contemporaneous or contiguous calcineurin inhibitor and sirolimus usage. As the intrarenal cyclosporin concentration is thought to be significantly elevated when cyclosporin and sirolimus are used together, this may explain these findings, and mandates caution in their co-administration. 相似文献
7.
8.
9.
10.
Serum and Cerebrospinal Fluid Pharmacokinetics of Intravenous and Oral Lamivudine in Human Immunodeficiency Virus-Infected Children 总被引:3,自引:3,他引:0
下载免费PDF全文
![点击此处可从《Antimicrobial agents and chemotherapy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Brigitta U. Mueller Linda L. Lewis Geoffrey J. Yuen Maureen Farley Amy Keller Joseph A. Church Jonathan C. Goldsmith David J. Venzon Marc Rubin Philip A. Pizzo Frank M. Balis 《Antimicrobial agents and chemotherapy》1998,42(12):3187-3192
We studied the pharmacokinetics of intravenously and orally administered lamivudine at six dose levels ranging from 0.5 to 10 mg/kg of body weight in 52 children with human immunodeficiency virus infection. A two-compartment model with first-order elimination from the central compartment was simultaneously fitted to the serum drug concentration-time data obtained after intravenous and oral administration. The maximal concentration at the end of the 1-h intravenous infusion and the area under the concentration-time curve after oral and intravenous administration increased proportionally with the dose. The mean clearance of lamivudine (± standard deviation) in the children was 0.53 ± 0.19 liter/kg/h (229 ± 77 ml/min/m2 of body surface area), and the mean half-lives at the distribution and elimination phases were 0.23 ± 0.18 and 2.2 ± 2.1 h, respectively. Clearance was age dependent when normalized to body weight but age independent when normalized to body surface area. Lamivudine was rapidly absorbed after oral administration, and 66% ± 25% of the oral dose was absorbed. Serum lamivudine concentrations were maintained above 1 μM for ≥8 h of 24 h on the twice daily oral dosing schedule with doses of ≥2 mg/kg. The cerebrospinal fluid drug concentration measured 2 to 4 h after the dose was 12% (range, 0 to 46%) of the simultaneously measured serum drug concentration. A limited-sampling strategy was developed to estimate the area under the concentration-time curve for concentrations in serum at 2 and 6 h. 相似文献